期刊文献+

海岛地区合并HBV感染的非霍奇金淋巴瘤临床研究 被引量:5

Clinical study of non-Hodgkin's lymphoma with HBV infection in island area
在线阅读 下载PDF
导出
摘要 目的:探讨非霍奇金淋巴瘤(NHL)与乙肝病毒(HBV)感染的相关性,以及合并HBV感染NHL的临床特征。方法:收集初诊NHL 312例,采用ELISA法检测HBV感染状态,并分析HBsAg阳性组和HBsAg阴性组的临床特征和治疗结果。结果:NHL患者HBsAg阳性率明显高于同期住院治疗的肿瘤患者(排除肝癌),临床特征中性别、年龄与乙肝感染相关性不大,不同病理类型中以弥漫大B细胞淋巴瘤HBsAg阳性率最高,差异有统计学意义(P<0.05)。HBsAg阳性组分期晚,治疗后有效率低,中位生存时间短,与HBsAg阴性组比较差异有统计学意义(P<0.05)。结论:HBV与NHL发病有一定的相关性,合并HBV感染的NHL预后较差。 Objective:To investigate the correlation between non-Hodgkin’s lymphoma(NHL)and hepatitis B virus(HBV)infection and the clinical features of NHL complicated with HBV infection.Method:A total of 312 cases of newly diagnosed NHL were enrolled.The infection status of HBV was detected by ELISA.The clinical characteristics and treatment results of HBsAg positive group and HBsAg negative group were analyzed.Result:The positive rate of HBsAg in NHL patients was significantly higher than in patients with other tumors in the same period of hospitalization(excluding hepatocellular carcinoma).There was no significant correlation among gender,age and hepatitis B infection.Diffuse large B-cell lymphoma had the highest positive rate among different types of NHL patients,and the difference was statistically significant(P<0.05).The patients in HBsAg positive group showed a late stage,a low effective rate and a short median survival time after treatment.There was significant difference between HBsAg positive group and HBsAg negative group(P<0.05).Conclusion:There is an unequivocal correlation between HBV infection and NHL pathogenesis.The prognosis of NHL with HBV infection is poor.
作者 竺枫 王宏强 杨序春 ZHU Feng;WANG Hongqiang;YANG Xuchun(Department of Hematology,Zhoushan Hospital,Zhoushan,316000,China)
机构地区 舟山医院血液科
出处 《临床血液学杂志》 CAS 2019年第2期210-212,共3页 Journal of Clinical Hematology
关键词 海岛地区 非霍奇金淋巴瘤 乙肝病毒 island area non-Hodgkin’s lymphoma hepatitis B virus
作者简介 通信作者:杨序春,E-mail:yangblood@163.com.
  • 相关文献

参考文献4

二级参考文献38

  • 1梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658. 被引量:967
  • 2VISCO C,FINOTTO S,ZAMBELLO R,et al.Combination of rituximab,bendamustine,and cytarabine for patients with mantle-cell non-Hodgkin lymphomaineligible for intensive regimens or autologous transplantation[J].J Clin Oncol,2013,31:1442-1449.
  • 3CHAUDHARI D,KHAN S,SALEEM A,et al.Obstructive jaundice as an initial manifestation of nonhodgkin lymphoma:treatment dilemma and high mortality[J].Case Rep Med,2013,2013:259642.
  • 4CHEN J,WANG J,YANG J,et al.Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapy[J].PLoS One,2013,8:e69400.
  • 5TONZIELLO G,PISATURO M,SICA A,et al.Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma[J].Infection,2013,41:225-229.
  • 6KIM Y M,JEONG S H,KIM J W,et al.Chronic hepatitis B,non-Hodgkin's lymphoma,and effect of prophylactic antiviral therapy[J].J Clin Virol,2011,51:241-245.
  • 7QIU M Z,RUAN D Y,WANG Z Q,et al.The expression of hepatitis B virus surface antigen in 120Hodgkin's lymphoma patients[J].Chin J Cancer,2010,29:735-740.
  • 8CHEN M H,HSIAO L T,CHIOU T J,et al.High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma[J].Ann Hematol,2008,87:475-480.
  • 9MA R,XING Q,SHAO L,et al.Hepatitis B virus infection and replication in human bone marrow mesenchymal stem cells[J].Virol J,2011,8:486.
  • 10TANAKA M,KATAYAMA F,KATO H,et al.Hepatitis B and C virus infection and hepatocellular carcinoma in China:a review of epidemiology and control measures[J].J Epidemiol,2011,21:401-416.

共引文献24

同被引文献56

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部